[小児科における体系的アプローチ:相互作用の複雑さを文脈化する]
Laurence Di Benedetto1, Pierre Ruffieux2, Charlotte Reith1
1Service de pédiatrie, Département femme-mère-enfant, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Revue medicale suisse
|February 19, 2026
まとめ
患者とは患者である.
科学分野:
- 家族システム理論 家族システム理論
- 医学社会学 医学社会学
- 医療心理学 心理学について
背景:
- 患者の健康は,相互に繋がっている家族,社会,医療システムによって影響を受けます.
- 病気,特に子供の病気は,既成の家族のダイナミクスと役割を大きく破壊します.
- 家族は,生物のように,ホメオスタシスを求め,内部/外部相互作用を修正することによって,病気に適応します.
研究 の 目的:
- 患者の病気が家族システムに与える影響を調査する.
- 患者さんの病気の間に家族が経験する適応プロセスの理解.
- 医療従事者のための体系的なアプローチの有用性を強調する.
主な方法:
- 家族の相互作用とダイナミクスの質的分析.
- 家族のライフサイクルの段階 (危機,移行,安定) を観察する.
- 患者とシステムの関係を理解するために,システム理論の適用.
主要な成果:
- 家族システムは,患者と相互に影響を及ぼし,全体的な健康結果に影響を与えます.
- 病気は,適応のダイナミックなプロセス,役割の変更,そして家族内のバランスの再確立を誘発します.
- 介護者は,家族が病気に適応する際の異なる段階を観察します.
結論:
- システミックなアプローチは,患者とシステムの相互作用の専門的な理解を高めます.
- 相互接続されたシステム内のリソース,ニーズ,困難を特定することは,効果的なソリューションの共同構築に不可欠です.
- 体系的なアプローチのトレーニングは,病気を通して患者とその家族をより良いサポートするために専門家に権限を与えます.
関連する概念動画
Pharmacokinetics in Pediatric Patients: Drug Metabolism
258
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
258
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
344
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
344
Pharmacokinetics in Pediatric Patients: Drug Excretion
289
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
289
Pharmacokinetics in Pediatric Patients: Drug Distribution
338
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
338
Factors Affecting Drug Response: Overview
3.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K
Drug Dosing: Infants and Children
344
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
344


